GLPG3067 single dose

DRUG2 trials

Sponsors

Galapagos NV

Conditions

Cystic FibrosisHealthy

Phase 1

A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG3067 in Healthy Subjects.

CompletedNCT03128606

Galapagos NVHealthy

Start: 2017-03-28End: 2018-02-20Updated: 2018-04-10

Pharmacokinetics of GLPG3067 in Male Subjects With Cystic Fibrosis.

CompletedNCT03589313

Galapagos NVCystic Fibrosis

Start: 2018-02-12End: 2018-03-26Updated: 2018-07-17